COVID-19 as Entrapment Syndrome for Human Society

     It is recommended by the U.S.A.’s Center for Disease Control (C.D.C.) which hereby should be referred to as Center for Death Control that in the current COVID-19 pandemic, all people in public areas should wear some sort of face mask or face covering to reduce transmission of COVID-19. It is believed that person wearing face mask will reduce transmission of COVID-19 if they are truly infected and also diminish chances of catching it from someone else. However, for the face mask wearer if he or she sneezes or coughs if they are infected, then re-entry of any infectious pathogens back into their oral and nasal cavities can occur since they are partially inhibiting expulsion of aerosols into the external air or disposable/washable materials like tissue paper, napkin, cloth handkerchief, etc.

     They can be self-infecting or auto-infecting with infectious particles due to voiding of droplets and aerosols into inner surface of face masks that serves as source of pathogens to re-enter or concentrate in mouth or nasal areas for re-entry into already infected oro-naso-pharyngeal or upper or lower respiratory tract to cause lingering, worsening or deeper infection. Hence, if one chooses not to wear face mask, he or she may risk exposure to airborne pathogens, but such has been the evolutionary existence of human beings to meet environmental challenges, strengthen innate immunity, and acquire adaptive immunity with non-lethal exposure to various pathogens in our daily lives, human history, and growth of population. Also, some clinical studies have indicated that in infectious illnesses without debilitating cough, it is better to cough away rather than use cough suppressing measures since clearance of respiratory pathogens is faster with healthy recovery.

     The simple layered face masks (homemade or otherwise) do allow for aerosols or very small liquid droplets less than 10 uM to pass through into the air; they are not impermeable to very small-sized aerosols. The average size of COVID-19 (also known as SARS-CoV-2 virus) virus particles is less than 2 uM (2 micron). The average COVID-19 virus particle size is 125 nanometers (0.125 microns); the range is 0.06 microns to .14 microns.¹  Check out the set-up of N.I.H.-funded study that measures distance, direction, and parameters of aerosols in daily activity called talking or speaking. It is claimed in such studies that projected aerosols can go linearly for certain distance. However, is the way these aerosols are projected or measured most accurate method to ascertain liquid droplets and aerosols kinetics while talking. It’s like people talking through an open-ended cup or tunneled opening to concentrate aerosols  while speaking into measurement chamber. Normal or real diffusion pattern of liquid droplets or aerosols while speaking is not reproduced in such a controlled set-up. Your tax dollars being put to smart, good use in such instances, right?!

How the N.I.H. Conducts Aerosols Transmission Experiments

Click Above Link to View

     Another salient point is that prompt and active COVID-19 infection in upper respiratory tract and in certain people subsequent lower respiratory system (lungs) means that it fights and overtakes the following measures inherent in the human body:
1) built-in mucosal immunity in respiratory tract or lining (See ciliary actions and phagocytosis),
2) innate immunity that is activated when foreign pathogens like coronaviruses enter the body (immunity based on 1 and 2 are tied together or overlap),
3) acquired, adaptive immunity (consisting of T- and B-cells) is also triggered and boosted into high drive when it encounters foreign pathogens or antigens (generally proteins or modified proteins present on cell surfaces or in fluid),
4) localized viral-inactivating activities like cytokines, complement system, and recruiting immune cells circulating throughout the body, and
5) previous exposure to sub-lethal or sub-clinical levels of COVID-19 (aka asymptomatic or even pre-symptomatic people who develop mild symptoms later) activating body’s immune cells (including memory cells) to be quickly dispatched to site of infection to fight and neutralize COVID-19 viral infection. Also, if the immune system has been challenged with similar or common proteins in different types of human coronaviruses (COVID-19 belongs to such family), then memory cells can mount a quick, robust response to fight COVID-19 before it can cause more damage to various systems in the body.

     There is more factual information to convey about human body’s immune system and public health officials’ actions is not intelligently based on known clinical evidence, valid and accurate scientific knowledge, and previous experiences with infectious agents in human history around the world. Stay tuned for more on this topic later…

1. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. (15 February 2020). “Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study”. The Lancet. 395 (10223): 507–513. doi:10.1016/S0140-6736(20)30211-7. PMC 7135076. PMID 32007143. Archived from the original on 31 January 2020. Retrieved 9 March 2020.